c3ar1 genetic expression data Search Results


gene exp c3ar1 mm02620006 s1  (Thermo Fisher)
87
Thermo Fisher gene exp c3ar1 mm02620006 s1
Gene Exp C3ar1 Mm02620006 S1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c3ar1+genetic+expression+data/Gene+Exp%2E+C3ar1%2C+Mm02620006_s1/pmc04696575-209-32-7
Average 87 stars, based on 1 article reviews
gene exp c3ar1 mm02620006 s1 - by Bioz Stars, 2026-11
87/100 stars
  Buy from Supplier
gene exp itga1 hs00235006 m1  (Thermo Fisher)
98
  Buy from Supplier
gene exp c3ar1 hs00269693 s1  (Thermo Fisher)
92
  Buy from Supplier

Image Search Results


Validation of selected target genes from the blue module in replication cohorts confirms differences between Th subsets, but not between HC and pSS patients. According to the criteria shown in <xref ref-type=Figure 3 and based on pathway enrichment analysis ( Figure 2 ) and literature, genes were selected from the blue module and were replicated by qPCR and flow cytometry. RNA sequencing data is shown in (A, C) , qPCR and flow cytometry data are shown in (B, D) , respectively. HOPX, SOX4, ITGA1, C3AR1 and ABCB1 were evaluated by qPCR in an additional replication cohort (B) . Genes encoding for surface proteins for which antibodies were available were replicated by flow cytometry: ITGAE (CD103), CD73 (NT5E), NCR3 (NKp30), CCR5 and ABCB1 (D) . NRC, normalized read counts; FC, fold change, DN HC mean is set at 1. *, **, *** indicates statistical significance of p < 0.05, 0.01, 0.001, respectively. " width="100%" height="100%">

Journal: Frontiers in Immunology

Article Title: Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren’s Syndrome Patients Identifies CCL5 as a Novel Effector Molecule

doi: 10.3389/fimmu.2021.702733

Figure Lengend Snippet: Validation of selected target genes from the blue module in replication cohorts confirms differences between Th subsets, but not between HC and pSS patients. According to the criteria shown in Figure 3 and based on pathway enrichment analysis ( Figure 2 ) and literature, genes were selected from the blue module and were replicated by qPCR and flow cytometry. RNA sequencing data is shown in (A, C) , qPCR and flow cytometry data are shown in (B, D) , respectively. HOPX, SOX4, ITGA1, C3AR1 and ABCB1 were evaluated by qPCR in an additional replication cohort (B) . Genes encoding for surface proteins for which antibodies were available were replicated by flow cytometry: ITGAE (CD103), CD73 (NT5E), NCR3 (NKp30), CCR5 and ABCB1 (D) . NRC, normalized read counts; FC, fold change, DN HC mean is set at 1. *, **, *** indicates statistical significance of p < 0.05, 0.01, 0.001, respectively.

Article Snippet: To validate RNA sequencing results, TaqMan assays were performed for selected target genes ( ITGA1 Hs00235006_m1, C3AR1 Hs00269693_s1, ABCB1 Hs00184500_m1, CCL5 Hs00982282_m1, SOX4 Hs04987498_s1 and HOPX Hs04188695_m1, and B2M Hs00187842_m1, all from ThermoFisher, LifeTechnologies) using RNA extracted from FACS sorted CCR9+, CXCR5+ and CCR9-CXCR5- Th cell subsets from HC and pSS patients as described above.

Techniques: Biomarker Discovery, Flow Cytometry, RNA Sequencing